Sponsoring Agency HHS
    POP 7/13/17 - 7/13/24 (7 years)


The Preclinical Models of Infectious Diseases program will include non-traditional animal models as well as models that could serve as replacements for animals in product screening and efficacy studies. The program will continue to provide the capability and capacity to develop and employ animal and animal replacement models (e.g., organ-on-a-chip technology) of infectious diseases for screening and product evaluation and address a critical stage in this pipeline by bridging in vitro testing and eventual clinical evaluation, including, as needed studies conducted under the guidance of 21 CFR 58, "Good Laboratory Practices".

  • $0 Aggregate Dollars Obligated
  • $0 Aggregate Base & Exercised Options
  • $0 Aggregate Base & All Options (Ceiling)

Market Stats Related Contracts